KMT2D and Fanconi anemia: Here, the authors show that KMT2D deficiency in HNSCC impairs the Fanconi Anemia (FA)/BRCA pathway under glycolytic inhibition, rendering HNSCC hypersensitive to DNA crosslinking agents and PARP inhibitors.